Founded in 2004, Omega Funds is a dedicated global life sciences investment firm headquartered in Boston, with additional operations in London and San Francisco.  Since its founding, the firm has raised $700M.  At its inception, the firm specialized in direct secondary transactions providing total or partial liquidity to investors unable to follow on their original investment. Currently deploying Omega Fund V, a $300M fund investing directly in public and private companies, across all healthcare and life sciences sectors, including biotech, medical devices, diagnostics, services and healthcare IT.  Omega also continues also continue to provide customized solutions for investors seeking partial or complete liquidity for their shareholdings.  Omega has a strong track record of identifying great management teams and companies and of backing them with capital, expertise and access to our network of relationships and resources, resulting in high-value exit outcomes